基因技术

GENE NASDAQ
1.770
+0.070
+4.12%
盘后: 1.800 +0.03 +1.69% 16:23 08/16 EDT
开盘
1.700
昨收
1.700
最高
1.840
最低
1.560
成交量
18.04万
成交均量(3M)
5.06万
52周最高
6.32
52周最低
1.560
换手率
4.09%
市值
780.01万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供基因技术 GENE股票价格,基因技术股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.
展开 >

最近浏览

名称
价格
涨跌幅